MedPath

MAXMIND PHARMACEUTICAL SL.

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:5
CIMA_AEMPS:3

Drug Approvals

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字HJ20240131
Approval Date
Nov 15, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字HJ20240132
Approval Date
Nov 15, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字HJ20240133
Approval Date
Nov 15, 2024
NMPA

Latanoprost Eye Drops

Product Name
拉坦前列素滴眼液
Approval Number
国药准字HJ20230111
Approval Date
Aug 28, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字HJ20220046
Approval Date
May 10, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.